(1'R,4'S)-9-[4-((N-(2-(methoxymethyloxy)benzoyl)sulfamoyl)oxymethyl)cyclopent-2-en-1-yl]adenine

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 核苷和核苷酸类似物
• 英文名称: (1'R,4'S)-9-[4-((N-(2-(methoxymethyloxy)benzoyl)sulfamoyl)oxymethyl)cyclopent-2-en-1-yl]adenine
• 英文别名: [(1S,4R)-4-(6-aminopurin-9-yl)cyclopent-2-en-1-yl]methyl N-[2-(methoxymethoxy)benzoyl]sulfamate
• 化学式: C₂₀H₂₂N₆O₆S
• 分子量: 474.497
• InChiKey: XXGJXYDJEUCOAM-KGLIPLIRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  33
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  169
• 氢给体数：
  2
• 氢受体数：
  10

反应信息

• 作为产物：
  描述：

  (1'R,4'S)-9-[4-(hydroxymethyl)cyclopent-2-en-1-yl]adenine 在 sodium hydride 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 乙二醇二甲醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 32.5h， 生成 (1'R,4'S)-9-[4-((N-(2-(methoxymethyloxy)benzoyl)sulfamoyl)oxymethyl)cyclopent-2-en-1-yl]adenine
  参考文献：
  名称：

  Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain

  摘要：

  Tuberculosis is the leading cause of infectious disease mortality in the world by a bacterial pathogen. We previously demonstrated that a bisubstrate inhibitor of the adenylation enzyme MbtA, which is responsible for the second step of mycobactin biosynthesis, exhibited potent antitubercular activity. Here we systematically investigate the structure-activity relationships of the bisubstrate inhibitor glycosyl domain resulting in the identification of a carbocyclic analogue that possesses a K-I(app) value of 2.3 nM and MIC99 values of 1.56 mu M against M. tuberculosis H37Rv. The SAR data suggest the intriguing possibility that the bisubstrate inhibitors utilize a transporter for entry across the mycobacterial cell envelope. Additionally, we report improved conditions for the expression of MbtA and biochemical analysis, demonstrating that MbtA follows a random sequential enzyme mechanism for the adenylation half-reaction.

  DOI：

  10.1021/jm061068d

文献信息

• Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain
  作者：Ravindranadh V. Somu、Daniel J. Wilson、Eric M. Bennett、Helena I. Boshoff、Laura Celia、Brian J. Beck、Clifton E. Barry、Courtney C. Aldrich

  DOI：10.1021/jm061068d

  日期：2006.12.1

  Tuberculosis is the leading cause of infectious disease mortality in the world by a bacterial pathogen. We previously demonstrated that a bisubstrate inhibitor of the adenylation enzyme MbtA, which is responsible for the second step of mycobactin biosynthesis, exhibited potent antitubercular activity. Here we systematically investigate the structure-activity relationships of the bisubstrate inhibitor glycosyl domain resulting in the identification of a carbocyclic analogue that possesses a K-I(app) value of 2.3 nM and MIC99 values of 1.56 mu M against M. tuberculosis H37Rv. The SAR data suggest the intriguing possibility that the bisubstrate inhibitors utilize a transporter for entry across the mycobacterial cell envelope. Additionally, we report improved conditions for the expression of MbtA and biochemical analysis, demonstrating that MbtA follows a random sequential enzyme mechanism for the adenylation half-reaction.